Quality of life outcomes of ECT

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Electroconvulsive therapy (ECT) continues to stand the test of time. There is a growing demand for patient reported outcome data including measures of HRQL, patient satisfaction and utility. ECT is efficacious for a number of psychiatric conditions but it is often reserved for the most ill patients because compared to drugs or psychotherapy it has a higher cost per unit of treatment, requires anesthesia, and because of a continuing stigma. As well, ECT has a particular set of side effects including the potential for memory impairment, and cardiac death. Mental illness produces profound deficits in HRQL and loss of HRQL is linear to severity of illness, and may therefore be part of decision to refer for ECT. At baseline studies have shown that ECT patients have reduced HRQL and functioning. ECT treatment improves HRQL and functioning in a lasting way for patients with major depression and schizophrenia. HRQL improvements are related to ECT's effect on mood whereas functional improvements are more closely related to cognition

Original languageEnglish (US)
Title of host publicationQuality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders
Subtitle of host publicationNew Perspectives on Research and Treatment
PublisherSpringer Netherlands
Pages321-331
Number of pages11
ISBN (Print)9781402057779
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Electroconvulsive Therapy
Quality of Life
Patient Satisfaction
Psychotherapy
Cognition
Psychiatry
Schizophrenia
Anesthesia
Depression
Costs and Cost Analysis
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rosenquist, P. B., & McCall, W. V. (2007). Quality of life outcomes of ECT. In Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment (pp. 321-331). Springer Netherlands. https://doi.org/10.1007/978-1-4020-5779-3_17

Quality of life outcomes of ECT. / Rosenquist, Peter B.; McCall, William Vaughn.

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment. Springer Netherlands, 2007. p. 321-331.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rosenquist, PB & McCall, WV 2007, Quality of life outcomes of ECT. in Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment. Springer Netherlands, pp. 321-331. https://doi.org/10.1007/978-1-4020-5779-3_17
Rosenquist PB, McCall WV. Quality of life outcomes of ECT. In Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment. Springer Netherlands. 2007. p. 321-331 https://doi.org/10.1007/978-1-4020-5779-3_17
Rosenquist, Peter B. ; McCall, William Vaughn. / Quality of life outcomes of ECT. Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment. Springer Netherlands, 2007. pp. 321-331
@inbook{88ba4b3f732b4014a95549db6b62bef6,
title = "Quality of life outcomes of ECT",
abstract = "Electroconvulsive therapy (ECT) continues to stand the test of time. There is a growing demand for patient reported outcome data including measures of HRQL, patient satisfaction and utility. ECT is efficacious for a number of psychiatric conditions but it is often reserved for the most ill patients because compared to drugs or psychotherapy it has a higher cost per unit of treatment, requires anesthesia, and because of a continuing stigma. As well, ECT has a particular set of side effects including the potential for memory impairment, and cardiac death. Mental illness produces profound deficits in HRQL and loss of HRQL is linear to severity of illness, and may therefore be part of decision to refer for ECT. At baseline studies have shown that ECT patients have reduced HRQL and functioning. ECT treatment improves HRQL and functioning in a lasting way for patients with major depression and schizophrenia. HRQL improvements are related to ECT's effect on mood whereas functional improvements are more closely related to cognition",
author = "Rosenquist, {Peter B.} and McCall, {William Vaughn}",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/978-1-4020-5779-3_17",
language = "English (US)",
isbn = "9781402057779",
pages = "321--331",
booktitle = "Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Quality of life outcomes of ECT

AU - Rosenquist, Peter B.

AU - McCall, William Vaughn

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Electroconvulsive therapy (ECT) continues to stand the test of time. There is a growing demand for patient reported outcome data including measures of HRQL, patient satisfaction and utility. ECT is efficacious for a number of psychiatric conditions but it is often reserved for the most ill patients because compared to drugs or psychotherapy it has a higher cost per unit of treatment, requires anesthesia, and because of a continuing stigma. As well, ECT has a particular set of side effects including the potential for memory impairment, and cardiac death. Mental illness produces profound deficits in HRQL and loss of HRQL is linear to severity of illness, and may therefore be part of decision to refer for ECT. At baseline studies have shown that ECT patients have reduced HRQL and functioning. ECT treatment improves HRQL and functioning in a lasting way for patients with major depression and schizophrenia. HRQL improvements are related to ECT's effect on mood whereas functional improvements are more closely related to cognition

AB - Electroconvulsive therapy (ECT) continues to stand the test of time. There is a growing demand for patient reported outcome data including measures of HRQL, patient satisfaction and utility. ECT is efficacious for a number of psychiatric conditions but it is often reserved for the most ill patients because compared to drugs or psychotherapy it has a higher cost per unit of treatment, requires anesthesia, and because of a continuing stigma. As well, ECT has a particular set of side effects including the potential for memory impairment, and cardiac death. Mental illness produces profound deficits in HRQL and loss of HRQL is linear to severity of illness, and may therefore be part of decision to refer for ECT. At baseline studies have shown that ECT patients have reduced HRQL and functioning. ECT treatment improves HRQL and functioning in a lasting way for patients with major depression and schizophrenia. HRQL improvements are related to ECT's effect on mood whereas functional improvements are more closely related to cognition

UR - http://www.scopus.com/inward/record.url?scp=84889955865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889955865&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-5779-3_17

DO - 10.1007/978-1-4020-5779-3_17

M3 - Chapter

AN - SCOPUS:84889955865

SN - 9781402057779

SP - 321

EP - 331

BT - Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders

PB - Springer Netherlands

ER -